Emory University Takes $1.71 Million Position in Versartis, Inc. (NASDAQ:VSAR)

The highest price VSAR stock touched in the last 12 month was $24 and the lowest price it hit in the same period was $2.35.

Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

While under theory that management are shareholders, many value investors look for stocks with a high percent of insider ownership, because they will act in its own self interest, as well create shareholder value in the long-term.

Piper Jaffray Companies cut shares of Versartis, Inc.

Rite Aid Corporation (RAD)
COPYRIGHT VIOLATION NOTICE: This story was originally published by TrueBlueTribune and is owned by of TrueBlueTribune. Personal Capital Advisors Corp acquired 81,879 shares as Archer Daniels Midland Co (ADM)'s stock declined 7.14%.

Versartis, Inc. (NASDAQ:VSAR) gross margin percentage stands at 0% while its operating margin for the past trailing twelve month is 0 percent and its overall profit margin (ttm) is 0 Percent. The company has a 50 day moving average of $18.37 and a 200-day moving average of $18.36. The market capitalization of the company is at $726.44 Million.

Versartis (NASDAQ:VSAR) last released its quarterly earnings data on Thursday, July 27th.

Previously Versartis Inc Cmn (NASDAQ:VSAR) reported $-1.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $-0.84 by $-0.2. Equities research analysts forecast that Versartis, Inc. will post ($3.61) EPS for the current fiscal year.

Versartis, Inc is an endocrine-focused biopharmaceutical company. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of U.S. & global copyright legislation. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/09/28/versartis-inc-vsar-major-shareholder-sells-7007700-00-in-stock.html.

Delta vai oferecer WhatsApp grátis em voos
O novo recurso faz parte de um investimento bilionário que a companhia vem fazendo para aprimorar a experiência do cliente. Os passageiros da empresa vão poder usar WhatsApp , iMessage e Facebook Messenger durante os voos sem precisar pagar nada.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Credit Suisse AG grew its stake in Versartis by 28.0% during the first quarter. Credit Suisse AG now owns 27,066 shares of the biopharmaceutical company's stock worth $576,000 after buying an additional 5,917 shares during the period. Teachers Advisors LLC grew its stake in shares of Versartis by 15.0% during the 4th quarter. Bank of America Corp DE now owns 9,482 shares of the biopharmaceutical company's stock valued at $203,000 after purchasing an additional 3,001 shares during the last quarter. Emory University acquired a new position in shares of Versartis during the second quarter worth $1,709,000. Cornerstone Capital Management Holdings LLC. increased its position in Versartis by 13.6% during the second quarter. Vanguard Group Inc. now owns 1,002,507 shares of the biopharmaceutical company's stock worth $21,404,000 after purchasing an additional 101,578 shares in the last quarter. Versartis has an average rating of Hold and an average target price of $8.20. Piper Jaffray Companies reissued a "buy" rating and issued a $26.00 target price on shares of Versartis in a research note on Friday, September 8th. September 22 investment analysts at Canaccord Genuity maintained a company rating of "Buy" and lowered the price expectation from $20.00 to $9.00. On September 22 the company was set at "Neutral" by PiperJaffray which is down from the previous "Overweight" rating. Where the relative strength index (RSI) is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine excess buying & selling conditions of an asset, it is one of the most popular technical indicators, computed on the basis of the speed and direction of a stock's price movement.

Consequently Genocea Biosciences (NASDAQ:GNCA)'s weekly and monthly volatility is 20.71%, 8.74% respectively.

Versartis, Inc.is headquartered in Redwood City, California. The Company is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase 2a clinical trials for the treatment of growth hormone deficiency.

Southern Coloradans with Puerto Rican ties say the island needs more help
About 10,000 containers are sitting in the port of San Juan because of what she calls a "jurisdictional situation". Hurricane Maria brought 100-plus miles per hour winds and extreme flooding to Puerto Rico .

Últimas notícias